tiprankstipranks
Natera reports Q4 EPS ($1.37), consensus ($1.42)
The Fly

Natera reports Q4 EPS ($1.37), consensus ($1.42)

Reports Q4 revenue $217.3M, consensus $215.55M. "We delivered another strong year in 2022, helping a record number of patients with their care," said Steve Chapman, Natera’s Chief Executive Officer. "We achieved important milestones that demonstrate the clinical utility of our tests, expanded coverage, and built on our leadership in evidence generation. Our guidance for 2023 reflects our expectations for robust top-line growth as we reduce operating expenses and continue to position the company for ongoing success."

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on NTRA:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles